Sensei Biotherapeutics

FDA clears Sensei’s IND to start Phase I/II therapy trial of SNS-101
Clinical Trials Arena
Fri, 04/21/23 - 10:04 am
Sensei Biotherapeutics
SNS-101
clinical trials
solid tumors
Life Sciences Companies Ringing the Nasdaq Bell this Week
BioSpace
Thu, 02/4/21 - 08:10 pm
IPOs
NASDAQ
Sana Biotechnology
Sensei Biotherapeutics
Landos Biopharma
Aspira Women's Health
Equillium
IPO tracker: 2021 gets started with a flurry of new offerings
Endpoints
Mon, 01/25/21 - 10:43 am
IPOs
Sana Biotechnology
Sensei Biotherapeutics
Bolt Biotherapeutics
Immunocore
Terns Pharmaceuticals
Pharvaris
Vor Biopharma
Adagene
NexImmune
Biophytis
Gracell Biotechnologies
Cullinan Oncology
Sensei raises $29M to advance anti-cancer bacteriophage pipeline
Fierce Biotech
Fri, 10/9/20 - 11:05 am
Sensei Biotherapeutics
SNS-301
Merck
Keytruda
bacteriophage